HANDLING USI20 Study: Satisfaction assessment and Good Usage Practice of RS01® versus Handihaler® inhalers in patients with COPD, a randomized comparative multicenter study

Satisfaction assessment and Good Usage Practice of RS01® versus Handihaler® inhalers in patients with COPD, a randomized comparative multicenter study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008893896971

Enrollment

Registered

2020-08-17

Start date

2020-07-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Sequence 2

Sequence 1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age ? 18 years old Informed consent, read and signed Patient with COPD No previous use of any of the study devices

Exclusion criteria

Exclusion criteria: Consent not signed

Design outcomes

Primary

Measure	Time frame
A satisfaction questionnaire was developped based on 20 items and administrated to the population study after using of the RS1 or the Handihaler inhalers. The primary endopoint is a quantitative criterion defined by of the number of subjects who had a final score = 80% iassessment questionnaires.	—

Secondary

Measure	Time frame
Mean score of the satisfaction questionnaire for each trial group	—

Countries

Tunisia

Contacts

Public ContactKarima Hezbri

Medical Science Liaison. OPALIA pharma RECORDATI Group

hezbri.k@opalia.com.tn+21658581952

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026